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Boston. Massachusetts
Preliminary reports have documented the utility of per-
cutaneous balloon valvuloplasty of the mitral valve in
adult patients with mitral stenosis , but the mechanism
of successful valve dilation and the effect of mitral val-
vuloplasty on cardiac performance have not been studied
in detail. Accordingly, mitral valvuloplast y was per-
formed in five postmortem specimens and in 18 adult
patients with rheumatic mitral stenosis, using either one
(25 mm) or two (18 and 20 mm) dilation balloons. Post-
mortem balloon dilation resulted in increased valve ori-
fice area in all five postmortem specimens, secondary to
separation of fused commissures and fracture of nodular
calcium within the mitral leaflets, In no case did balloon
dilation result in tearing of valve leaflets, disruption of
the mitral ring or liberation of potentially embolic de-
bris.
Percutaneous mitral valvuloplasty in 18 patients with
severe mitral stenosis (including 9 with a heavily calcified
valve) resulted in an increase in cardiac output (4.3 ::t
1.1 to 5.1 ± 1.5 liters/min, p < 0.01) and mitral valve
area (0.9 ± 0.2 to 1.6 ± 0.4 cm-, p < 0.0001), and a
decrease in mean mitral pressure gradient (15 ± 5 to 9
± 4 mm Hg, p < 0.0001), pulmonary capillary wedge
pressure (23 ± 7 to 18 ± 7 mm Hg, p < 0.0001) and
mean pulmonary artery pressure (36 ± 12 to 33 ± 12
The technique of percutaneous mitral valvuloplasty through
a transseptal approach was first described by Lock et al. (I)
and Rocchini et al. (2), who documented successful balloon
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mm Hg, P < 0.01). Left ventriculography before and
after valvuloplasty in 14 of the 18 patients showed a mild
(:51 +) increase in mitral regurgitation in five patients
and no change in the remainder. Embolic phenomena
were not observed in any patient.
Serial radionuclide ventriculography showed an in-
crease in left ventricular peak filling rate (2.20 ± 1.20
to 2.50 ± 1.20 end-diastolic volumes per second [EDV/s],
p < 0.05). Serial echocardiography/phonocardiography
showed improvement in mitral valve excursion (11 ± 6
to 14 ± 6 mm, p < 0.001), mitral EF slope (7 ± 4 to
13 ± 5, p < 0.001) , left atrial diameter (5.7 ± 0.9 to
5.3 ± 0.8 em, p < 0.001), Sropcning snap interval (0.07
± 0.03 to 0.08 ± 0.02 second, p < 0.02) and mitral
valve area (0.9 ± 0.2 to I.S ± 0.4 em", p < 0.0001).
All patients were discharged from the hospital with de-
creased symptoms after valvuloplasty.
It is concluded that percutaneous mitral valvuloplasty
can be performed in adult patients with mitral stenosis,
including patients with calcific disease, and can result
in significant improvement in valvular function. The
mechanisms of successful dilation include commissural
separation and fracture of nodular calcium.
(J Am Coll CardioI1987;9:723-3l)
dilat ion of the mitral valve in adolescent s with critical mitral
stenosis. Zaibag et al. (3) utilized a similar transseptal ap-
proach with a double balloon technique in successfully treat-
ing seven of nine adult patient s with symptomatic , noncal-
cified mitral stenosis. More recentl y, our laboratory (4) and
that of Palacios et al. (5) have extended the application of
this technique to older patients with calcific mitral valve
disease , including those in whom surgical intervention was
deferred because of high expected surgical risk . Although
all of these preliminary reports have suggested a favorable
hemodynamic response to balloon dilation, the pathologic
mechanism of mitral valvuloplasty and the effect of balloon
0735-I097/87/$J .50
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dilationon cardiac functionhave not beenpreviously studied
in detail. Accordingly, the purpose of this study was to
assess the effect of mitral valvuloplasty on valvularanatomy
and ventricular function in five postmortem specimens and
in 18 adult patients with symptomatic, rheumatic mitral
stenosis.
Methods
Postmortem valve dilation. Five patients undergoing
postmortem examination between August I, 1985 and Au-
gust I, 1986 who had evidence of mitral stenosis were
included in this study. The mitral valve was examined by
a pathologist to determine the presence of commissural fu-
sion, the presence of nodular calcification and the degree
of leaflet distortion. Mitral valvuloplasty was accomplished
subsequently with a 25 mm valvuloplasty balloon (Medi-
tech) with a maximal balloon inflation to 3 atm for a 30
second period. Afterdilation, the valve wasexamined grossly
for evidence of commissural separation, leaflet fracture,
valve ring distortion, calcific debris and changes in leaflet
mobility. In three of the five specimens, X-ray films were
taken before and after valvuloplasty to identify calcific frac-
tures.
Percutaneous mitral valvuloplasty study group (Table
1). Percutaneous balloon mitral valvuloplasty was per-
formed in 18patients with severe mitral stenosis. The study
group consisted of 13 women and 5 men with a mean age
of 49 years (range 23 to 75). All patients were symptomatic
with congestive heart failure. Predominant symptoms re-
ported by the study group included dyspnea on exertion in
18, orthopnea in 18 and weakness or fatigue in 7 patients.
Each patient had previously undergone recent cardiac cath-
eterization and coronary angiography. The origin of mitral
stenosis was presumed to be rheumatic in all cases. Nine
patientshad fluoroscopic evidence of extensive mitral valve
calcification, including mitral anular calcification. Five pa-
tients had atrial fibrillation and the remainder had normal
sinus rhythm. Four patients had significant coronary artery
disease, including two with severe three-vesseldisease, one
with two-vessel disease and one with one-vessel disease.
The remaining 14 had normal coronary arteries. No patient
had a prior historyof strokeor embolicphenomena. Patients
with evidence of left atrial thrombus on echocardiographic
study were not considered candidates for balloon mitral
valvuloplasty.
Each patient was evaluatedby a cardiac surgeon and was
offered mitral valve replacement, with an estimation of ex-
pected surgical risk. Fifteen patients were considered ex-
cellent surgical candidates. The remaining three (Cases I,
3 and 17) were considered high risk surgical candidates,
two because of severe obstructivechronic lung disease and
severe pulmonary hypertension and the third because of
severe three vessel coronary artery disease and pulmonary
hypertension. All 18 patients refused surgical intervention.
Each patient subsequently gave informed consent for per-
cutaneous mitral valvuloplasty after being informed of the
risks and potential complications of the procedureaccording
to a protocol approved by the Beth Israel Hospital Human
Investigations Committee.
Table 1. Clinical Characteristics of Patients Before Mitral Valvuloplasty
Mitral
Yalve Other
Calcification Disease
+ I YD,COPD
+ 3 YD,MI,AFlB
+ AFIB
+ AFIB
+
+ 2 YD,AFIB
+ 3 YD
AI
Mitral
Patient Age (yr) Yalve Area
No. &Sex Symptoms (ern")
I 75M d.o.w 0.6
2 42F d.o 1.0
3 13M d.o.w 0.6
4 59F d.o.w 1.0
5 53F d.o.w 1.2
6 54M d.o.w 0.7
7 56F d.o 1.2
8 29F d.o 0.8
9 71F d,o,w 0.9
10 67M d,o 0.8
II 35F d.o 0.9
12 34F d.o 1.3
13 27F d.o 1.0
14 32F d.o 0,8
15 46F d.o 0.8
16 39F d.o 1.4
17 63F d.o.w 0.6
18 23M d,o 1.0
+
+ AFIB,COPD
AFIB = atrial fibrillation; AI = aortic insufficiency; COPD = chronic obstructive lung disease; d =
dyspnea on exertion; F = female; M = male; MI = prior myocardial infarction; 0 = orthopnea; I YD, 2
YD or 3 YD = one, two or three vessel coronary artery disease, respectively; w = weakness/fatigue.
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Mitral valvuloplasty protocol (Fig. 1). After adminis-
tration of a local anesthetic, the left femoral artery and left
and right femoral veins were instrumented with 8F Hemokit
sheaths. Left and right heart catheterization using a 7F pig-
tail catheter and a 7F balloon flotation catheter, respectively.
was subsequently performedfrom the left groin. During the
right heart catheterization, a diagnostic oxygen saturation
series was obtained. After placement of the left and right
heart catheters, measurements were made of systemic ar-
terial. left ventricular, pulmonary capillary wedge and pul-
monary artery pressures and of pulmonary artery and left
ventricular oxygen saturations. Pulmonary capillary wedge
pressure was confirmedby aspirating blood from the wedge
position and subsequently documenting an arterial oxygen
saturation. Oxygen consumptionwas measuredusing a met-
abolic rate meter (Waters). After the completionof pressure
measurements , left ventriculography was performed in 14
of the 18 patients in the routine manner.
After prevalvuloplasty measurements, transseptal cath-
eterization was accomplished by standard technique using
a 8F Mullins transseptal sheath and dilator (USCI) and
Brockenbrough needle (6). After entry into the left atrium,
the needle and dilator were removedand a 7F balloon-tipped
end-hole catheter (Critikon) was advanced through the sheath
to the left atrium. Left heart pressures and transvalvular
gradient were then measureddirectly to corroborate the pre-
viously obtained wedge pressure measurements. The 7F
balloon catheter was then advanced through the mitral and
aortic valves to the descending thoracic aorta. followed by
insertionof an 0.038 inch (0.097 em), 300 em long Teflon-
coated exchange guide wire through the flow-directed cath-
eter. The sheath and balloon catheter were then removed,
leaving only the guide wire in place.
Next. an 8F angioplasty catheter (Meditech) with an 8
mm balloon was advanced over the guide wire to the level
of the interatrial septum and inflated to dilate the septal
opening. After removalof this catheter, a 9F balloondilation
catheter with a 25 mm balloon was advanced across the
septum to the left ventricle and positioned across the mitral
anulus. The balloon was subsequently inflated for 10 to 15
seconds with a mixture of saline solution and radiographic
contrast medium (Angiovist). Repeat inflations were made
until a waist in the balloon at the level of the mitral valve
was noted to disappear. Immediately after balloon valvu-
loplasty. all hemodynamic measurements were repeated.
including determination of transvalvular gradient and car-
diac output. Left ventriculography and a right heart oximetry
series were also repeated to document changes in the degree
of mitral regurgitation and to search for evidence of a new
left to right shunt, respectively. Mitral valve area before
and after valvuloplasty was calculatedby the Gorlin formula
using systemic blood flow for cardiac output, when appro-
priate (7).
In four patients (Cases 14 to 17), valve dilation was
accomplished utilizing two (18 and 20 mm) valvuloplasty
balloons. rather than a single 25 mm valvuloplasty balloon.
In these patients. after placement of a single guide wire
through the mitral orifice as described, a second guide wire
was similarly placed using a double lumen 7F exchange
catheter (Meditech) that accommodates two guide wires.
The exchange catheter was subsequently removed, and the
18 and 20 mm dilation balloons were positioned over the
two guide wires in the mitral apparatus before simultaneous
inflation to effect valve dilation.
All patients were treated with a total of 10.000 units of
intravenous heparin immediately after transseptaI catheter-
ization. All procedures were performed without surgical
backup.
Serial radionuclide ventriculography. Serial radio-
nuclide ventriculography was performed 24 hours before
and 48 hours after mitral valvuloplasty. Each patient was
injected with0.75 GBq (20 mCi) of technetium-99M-labeled
autologous red blood cells, with an in vitro technique used
for labeling. Radionuclide ventriculograms were obtained
Figure 1. Left panel, Photograph of
8 mm balloon used to dilate the inter-
atrial septum(lAS), marked bya waist
in the inflated balloon profile (dark
arrow). Right panel, Photograph of
25mm balloon used todilate the mitral
valve orifice (MVO), marked bya waist
in the inflated balloon profile (dark
arrow). Theballoon catheters used to
dilate theinteratrial septum and mitral
valve are positioned over a guide wire
(light arrows) that is placed by trans-
septal catheterization from the left
atrium through the mitral and aortic
valves to thedescending aorta.
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with the patient in a supine position in the anterior. left
posterior oblique and modified left anterior oblique views
using a mobile Anger camera computer system (Technicare
410) with an on-board VIP computer system. All radio-
nuclide scans were obtained using a high sensitivity slant-
hole collimator used to obtain 30° of cephalic angulation
for the modified left anterior oblique view. Scans were ob-
tained using a 64 x 64 matrix with a full fielded view (250
em). Thirty-two frames per RR interval were acquired to a
total of 10 million counts with an acquisition time of 5 to
8 minutes per view.
Left and right ventricular global ejection fra ction.
stroke/volume ratio and left ventricularpeak filling rate were
subsequently determined from each modified left anterior
oblique view (8).
Serial echocardiographic studies. Phonocardiography
and imaging/Doppler echocardiography were obtained 24
hours before and 48 hours after mitral valvuloplasty. M-
mode echocardiograms were obtained using an Irex System
II or ATL Mark 600 echocardiograph. Two-dimensionaland
Doppler studies were performed with the ATL equipment.
The following data were subsequently determined in each
patient: S2-opening snap interval, presence of mitral valve
thickening, mitral valve excursion, mitral EF slope and left
atrial diameter (9).
Severit y of mitral stenosis and mitral regurgitation was
assessed using pulsed Doppler echocardiography (10). In
the case of mitral regurgitation, the left atrium above both
mitral leaflets was interrogated using parasternal long-axis
and apical long-axis, four chamber and two chamber views.
The severity of mitral regurgitation was graded as trace.
mild. moderate or severe depending on the extension of the
signal of mitral regurgitation from the mitral leaflets to the
back wall of the left atrium.
From pulsed Doppler recordings within the stenotic mi-
tral jet (obtained with sample volume placement on the
ventricular side of the mitral valve using apical views). the
pressure half-time was calculated, and mitral valve area
(MVA) was then estimated from the formula (10)
MVA (cnr') = 220/pressure half-time (ms).
The diagnosis ofatrial septal defect flow was made using
pulsed Doppleror contrast echocardiography or both (11,12).
For pulsed Doppler echocardiography, the sample volume
was placed on the right atrial side of the interatrial septum,
using a subcostal view. Shunt flow from the left to the right
atrium was recognized by the presence of continuous tur-
bulence. maximal during late systole and early diastole.
Contrast echocardiography was performed after the injection
of agitated saline solution, mixed with the patient's own
blood, into an antecubital vein. A communication between
the right and left atria was diagnosed if there was a sub-
sequent negative contrast effect in the right atrium or a
positive contrast appearance in the left heart chambers. or
both.
Statistics. Meanand standard deviation were determined
for all variables. Paired dimensional data were analyzed by
either the paired t test or Wilcoxon signed-rank test where
appropriate. for parametric and nonparametric distributions.
A probability value of < 0.05 was considered signifi cant.
Results
Postmortem Valvuloplasty
Balloon dilation was performed in fi ve postmortem hearts
with calcific mitral stenosis. The mean age of the patients
at the time of death was 79 years. All patients had critical
mitral stenosis with a mean valve area of 0.9 ± 0.3 ern?
documented before death. All five specimens demonstrated
fusion of both commissures and extensive nodular calcifi -
cation.
In each of the five cases, balloon dilation using a 25 mrn
balloon resulted in increased orifice area without tearing of
valve leaflets, disruption of the valve ring or dislodgment
of potentially embolic material. In four of the five cases,
valvuloplasty resulted in complete or partial separation of
the fused edges of both commissures; in the remaining spec-
imen, balloon dilation resulted in complete separation of
only one commissure. In two of the three cases in which
radiographs were taken before and after dilation, valvulo-
plasty resulted in fractures of nodular calcium within the
mitral leaflet. An example of postmortem specimen before
and after dilation is shown in Figure 2.
Clinical Data
Hemodynamic changes associated with percutaneous
valvuloplasty (Table 2). Hemodynamically successful bal-
loon dilation was accomplished in all 18 patients as evi-
denced by a decrease in mean mitral gradient from 15 ±
5 to 9 ± 4 rnrn Hg (p < 0.0001). and an increase in cardiac
output from 4.3 ± 1.1 to 5.1 ± 1.5 liters/min (p < 0.01)
and calculated mitral valve area from 0.9 ± 0.2 to 1.6 ±
0.4 crrr ' (p < 0.000 I). Immediately after valve dilation,
there was a decrease in pulmonary capillary wedge pressure
(23 ± 7 to 18 ± 7 rnm Hg, p < 0.0001 ) and mean pul-
monary artery pressure (36 ± 12 to 33 ± 12 mm Hg, p
< 0.0 I), with no significant change in left ventricular pres-
sure (119 ± 24/11 ± 5 to 114 ± 1911 3 ± 5 mm Hg, p
= NS) or pulmonary vascular resistance (252 ± 187 to
254 ± 131 dynes' s'cm- s, p = NS).
In all 18 patients, a waist was noted to disappear in the
dilation balloon or balloons during maximal inflation. Dur-
ing the 10 to 15second period of balloon inflation, systemic
arterial pressure dropped precipitously with the appearance
of presyncopal symptoms in 5 of the 18 patients, followed
by the returnof baseline arterial pressures and disappearance
IACC Vol. 9. No.4
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A
Figure 2. Photographs of postmortem specimen from a patient
with rheumatic mitral stenosis before (A) and after (8) dilation
with a 25 mm valvuloplasty balloon; note separation of fused
cornrnissures after valvuloplasty.
of presyncopal symptoms immediately on balloon deflation.
In no case was balloon dilation accompanied by embolic
phenomena.
Mitral regurgitation after valvuloplasty (Table3). Left
ventriculography was performed in 14 of the 18 patients
before and after valvuloplasty. Before valvuloplasty. mitral
regurgitation was considered to be absent in eight patients.
trace in four patients. mild( I + ) in one patient and moderate
(2 + ) in one patient. Afterdilation, there was a mild ( :s I + )
increase in mitralregurgitation in five patients and nochange
in the remaining nine.
Doppler echocardiographic studies obtained in 15of the
18 patients demonstrated an increase in mitral regurgitation
in 3 patients, a decrease in 2 and no change in the remain-
ing 10.
Presence of an interatrial shunt after valvuloplasty
(Table 4). Serial right heart diagnostic oxygen saturation
series documented the presence of a significant right atrial
oxygen "step-up" in 5 of the 18 patients; calculated pul-
monary to systemic flow (QplQs) ratios were 1.1 , 1.1 , 1.4,
1.8 and 2.3, respectively.
Doppler or contrast echocardiogr aphy performed in 15
of the 18 patients documented the presence of a small in-
teratrial shunt in five patients, including one patient not
detected by the oximetry series. There were no significant
differences in hemodynamic changes after valvuloplasty in
patients with or without an atrial septal defect.
Serial radionuclide ventriculography. This procedure
was performed in 13 of the 18 patients. Balloon valvulo-
plasty resulted in no significant change in left ventricular
ejection fraction (57 ± 16 to 56 ± 13%, P = NS), right
ventricular ejection fraction (43 ± /8 to 41 ± 15%, P =
NS) or stroke/volume ratio (1.30 ± 0.50 to 1.20 ± 0.40,
p ~ NS). There was, however. a significant increase in left
ventricular peak filling rate (2.20 ± 1.1 0 to 2.50 ± 1.20
EDV/s. p < 0.05).
Serial phonocardiography/echocardiography (Table
5). These studies were obtained in 15of 18patients. All pa-
tients were foundto haveabnormal mitralvalvemotiononM-
mode and two-dimensionalechocardiography, characteristic
for rheumatic deformity. Mitral valve fibrosis was classified
as mild in five patients, moderate in four and severe in six.
Balloon valvuloplasty resulted in signifi cant changes in
mitral valve excursion (II ± 6 to 14 ± 6 mm, p < 0.00I).
mitral EF slope (7 ± 4 to 13 ± 5, p < 0.001), left atrial
diameter (5.7 ± 0.9 to 5.3 ± 0.8 em, p < 0.001), Sr
opening snap interval (0.06 ± 0.03 to 0.08 ± 0.02 second,
p < 0.02) and mitral valvearea determined by Dopplerhalf-
time pressure (0.9 ± 0.2 to 1.5 ± 0.4 ern", p < 0.0001 ).
Clinical follow-up. All 18 patients noted significant re-
duction in symptoms of dyspnea on exertion. orthopnea and
weakness after valvuloplasty. One patient (Case I) was re-
catheterized at 6 months and found to have progressive
hemodynamic improvement. including no evidenceof valve
restenosis (valve area 0.6 ern? before dilation, 1.4 crrr ' im-
mediately after dilationand 1.4 crrr' 6 months after dilation).
a decrease in mitral regurgitation from moderate to trace
and further decreases in pulmonary capillary wedgepressure
and pulmonary vascular resistance. Nine patients (Cases I
to 4, 7 to 11 ) had repeat echocardiographic studies 4 to 6
weeks after dilation with no evidence of valvular restenosis.
Two patients (Cases 3 and 4) in whom balloon dilation
resulted in a minimal increase in mitral valve area noted
recurrent symptoms 3 months after dilation and subse-
quently underwent operative mitral valve replacement with
728 McKAY ET AL.
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Table 2. Hemodynamics Before and After Valvuloplasty in 18 Patients
Mitral
Gradient Cardiac Output Mitral Valve PCW
Patient
(mm Hg) (liters/min) Area (em') (mm Hg)
No. Before After Before After Before After Before After
I 18 12 3.3 4.7 0.6 1.4 28 23
2 18 15 5.6 9.6 1.0 2.2 26 25
3 15 12 3.0 4.0 0.6 1.0 26 22
4 13 9 4.5 5.2 1.0 1.3 28 28
5 8 5 4.4 4.8 1.2 1.8 10 8
6 15 II 4.0 6.0 0.7 1.2 30 24
7 7 6 3.9 4.2 1.2 1.7 16 8
8 15 7 5.1 5.6 0.8 1.6 29 16
9 10 4 3.3 3.5 0.9 1.5 24 18
10 21 14 4.3 4.4 0.8 1.2 25 18
II 23 13 5.6 6.0 0.9 1.5 30 20
12 10 3 5.8 4.9 1.3 2.1 14 12
13 10 5 3.5 3.8 1.0 1.5 14 9
14 16 8 3.7 5.3 0.8 1.8 25 19
15 18 II 4.0 4.6 0.8 1.4 26 16
16 16 7 6.9 6.6 1.4 2.4 15 7
17 14 10 2.9 3.0 0.6 0.9 19 23
18 25 9 4.1 5.3 1.0 1.6 35 24
Mean 15 9 4.3 5.1 0.9 1.6 23 18
SO 5 4 1.1 1.5 0.2 0.4 7 7
** * ** **
LVSP LVEOP PA PVR
Patient
(rnrn Hg) (mm HgJ (rnm Hg) (dynes-s-cm 5)
No. Before After Before After Before After Before After
I 113 108 10 15 54 50 630 460
2 112 122 14 18 43 46 243 175
3 95 80 15 12 52 49 693 540
4 190 166 15 19 42 44 249 246
5 150 129 7 5 23 19 236 183
6 113 127 14 17 50 48 348 320
7 102 95 6 7 23 20 143 228
8 103 97 14 15 48 38 298 314
9 116 116 24 15 30 28 145 229
10 121 108 10 15 44 35 353 309
II 102 108 10 15 44 35 200 200
12 120 112 6 12 25 24 152 195
13 110 112 9 15 18 16 91 147
14 106 110 II 14 27 26 43 106
15 136 136 II 8 38 36 240 348
16 85 92 2 I 17 10 23 36
17 143 117 7 16 32 34 359 293
18 130 120 8 12 40 40 98 242
Mean 119 114 II 13 36 33 252 254
SO 24 19 5 5 12 12 187 131
*
*p < 0.0 I; **p < 0.0001. Cardiac output reported here represents systemic blood flow calculated by the
Fick method. When postvalvuloplasty oximetry series demonstrated an interatrial shunt, systemic blood flow
was calculated using the formula of Flamm et al. (13). LVEOP = left ventricularend-diastolic pressure; LVSP
= left ventricular systolic pressure; PA = mean pulmonary artery pressure; pew = pulmonary capillary
wedge pressure; PVR = pulmonary vascular resistance.
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Table 3. Assessment of Mitral Regurgitation Before and After
Valvuloplasty in 18 Patients
Patient
Ventriculography Doppler
No. Before After Before After
I 1+ 2+ 2+ 2+
2
3 Trace Trace Trace Trace
4 2+ 2+ 2+ 2+
5 Trace
6 1+ 1+
7 Trace Trace Trace Trace
s
9 NA NA Trace
10 Trace 1+ 1+
II Trace Trace
12 NA NA
13 Trace NA NA
14 Trace Trace
15 NA NA
16 NA NA
17 NA NA
IX Trace Trace NA NA
Mitral regurgitation is graded on a scale of trace. 1+ (mild). 2+
(moderate). 3+ (moderate to severe) and 4 + (severe). Doppler = Doppler
echocardiography: NA = not assessed: - = absent.
a good result. At the time of surgery, there was incomplete
separation of fused commissures in both of these patients
suggesting inadequate balloon dilation. The remaining 16
patients have remained symptom free (the longest clinical
follow-up has been 12 months).
ment (14), that our study group was small and that two
patients eventually required mitral valve replacement. Ad-
ditional studies will be needed to evaluate the role of per-
cutaneous balloon dilation, including careful long-term fol-
lOW-Up to assess mitral valve restenosis. Nevertheless, at
least two groups of patients theoretically may benefit from
mitral valvuloplasty. First, in patients who are considered
at high surgical risk for mitral valve replacement or who
are refused surgery, mitral valvuloplasty may offer a po-
tential nonsurgical alternative. This group may include, for
example, patients with advanced age, severe pulmonary
hypertension, coronary artery disease, associated aortic and
tricuspid valve disease, renal failure and pulmonary dys-
function. A second group of patients in whom valvuloplasty
may have a role includes younger patients who are not
optimal candidates for placement of a porcine valve because
of the high incidence of calcification of these valves (15),
or for whom chronic anticoagulation is also undesirable (for
example, young women who wish to become pregnant).
Anatomic mechanism of valve dilation. Postmortem
valve dilations in this study have documented that successful
balloon valvuloplasty may result from both separation of
fused commissures and fracture of nodular calcium. It is
presumably the former mechanism that is operative in young
patients with noncalcitied disease. Similar mechanisms of
successful valvuloplasty have been noted by our laboratory
in postmortem specimens of calcific aortic stenosis (16).
Single or double balloon technique. At least two tech-
niques have been reported to be successful in the balloon
dilation of stenotic mitral valves, both involving a trans-
Table 4. Detection of Left to Right Shunts After Valvuloplasty
in III Patients
Hubble = contrast echocardiography: NA = not assessed: Qr/Q, =
pulmonary to systemic blood flow: + = present: - = minus.
Discussion
In previous series of percutaneous balloon mitral com-
missurotomy by a transseptal approach (1-3), patients with
evidence of mitral regurgitation or mitral calcification were
excluded. The present study complements these previous
reports and indicates that mitral valvuloplasty may also be
performed in adult patients with mild mitral regurgitation
and severe calcific mitral stenosis, without embolic phe-
nomena or major increases in valvular regurgitation. Im-
provement in valvular function has been documented by a
decrease in mitral gradient and left atrial size, and by an
increase in cardiac output, mitral valve area, mitral valve
excursion, mitral EF slope, STopening snap interval and
left ventricular peak filling rate. Although immediate hemo-
dynamic improvement occurred in all patients, two patients
with minimal clinical improvement required valve replace-
ment within 3 months after valve dilation.
Clinical indications. This study has not documented the
efficacy of percutaneous mitral valvuloplasty as a routine
treatment for adult patients with critical mitral stenosis,
given the facts that mitral valve surgery can usually be
performed with low risk and marked functional improve-
Patient
No.
7.
3
4
5
f>
7
H
':I
10
II
12
13
14
15
Ih
17
IX
Q,JQ, by
RIght Heart
Oximetry Series
I.X
1.1
1.1
:u
1.4
Echocardiography
Doppler/Bubble Study
+
+
+
+
+
NA
NA
730 McKAY ET AL.
MITRAL VALVE VALVULOPLASTY
lACC Vol. 9. No, 4
April 19S7:723-31
TableS. Echocardiographic Results Before and After Valvuloplasty in 15 Patients
MY Excursion EF Slope S,-OS MYA LA Size
Patient
(rnm) (mm/s) (seconds) (cnr') (ern)
No. Before After Before After Before After Before After Before After
7 8 13 10 NA NA 0.6 1.5 5.8 5.8
2 13 17 4 14 0.06 O.OS O.S 1.7 5.6 4.9
3 6 10 I 9 0.05 0.05 0.9 1.4 5.9 5.6
4 6 13 8 12 0.12 0.10 OS 0.9 7.1 6.0
5 19 24 7 12 0.11 0.10 1.1 2.0 5.4 5.4
6 7 9 9 15 0.04 0.07 0.7 J.2 6.5 6.0
7 12 17 10 14 0.09 0.09 O.S J.2 5.0 43
8 18 23 7 12 (l.O4 0.10 0.6 J.2 5. I 4.5
9 6 9 10 6 (l.O8 O.OS 0.9 1.4 7.8 7.2
10 8 8 0 6 0.04 0.06 1.1 1.5 5.8 6.0
II 16 16 0 10 0.03 0.07 1.0 1.6 5.9 5.3
12 NA NA NA NA NA NA NA NA NA NA
IJ NA NA NA NA NA NA NA NA NA NA
14 23 21 7 21 0.09 0.10 0.8 I.S 4.5 4.1
15 9 12 10 19 0.09 0.11 1.1 1.7 5.3 5.2
16 15 15 8 23 0.04 0.07 1.4 2.3 4.5 4.2
17 3 8 12 IS 0.05 0.07 1.0 1.6 5.3 5.2
18 NA NA NA NA NA NA NA NA NA NA
Mean II 14 7 13 0.07 0.08 0.9 1.5 5.7 5.3
SD 6 6 4 5 0.03 0.02 0.2 0.4 0.7 0.8
** ** * *** **
*p < 0.02; **p < 0.00 I; *** P < 0.00 I. EF slope = mitral valve EF slope; LA size = left atrial diameter;
MY = mitral valve; MYA = mitral valve area by Doppler pressure half-time; S,-OS = duration of S,-opening
snap interval.
septal approach. Our laboratory (4) and that of Palacios et
al. (5) have reported using a single 25 mm balloon intro-
duced after dilation of the interatrial septal puncture. Zaibag
et al. (3) used a double-balloon technique involving two
transseptal punctures to position two smaller balloons in the
mitral anulus, thereby avoiding dilation of the atrial septum.
Variations of both of these techniques are obviously pos-
sible. For example, in the four patients in the present study
in whom two balloons were utilized, only one transseptal
procedure was performed to place a single guide wire across
the mitral apparatus; the second guide wire was subsequently
positioned using a double lumen exchange catheter that could
accommodate two guide wires simultaneously. Theoretic
advantages of the single balloon technique include the need
for only one transseptal procedure and the technical feasi-
bility of placing only one guide wire and one balloon. Al-
ternatively. the double balloon technique may not require
dilation of the interatrial septum and may provide the largest
dilating balloon volume with the use of two balloons.
Additional variations in the technique will presumably
accompany technologic improvements in valvuloplasty
equipment. As with coronary angioplasty, it is probable that
the technique of mitral valvuloplasty will change dramati-
cally with improvements in design and construction of bal-
loon dilation catheters. Decreases in deflated balloon pro-
files, shortening of inflation and deflation time, changes in
catheter stiffness and changes in balloon shape are all ex-
amples of potential balloon modifications that may make
valvuloplasty easier to perform.
Complications. Six of the 18 patients in this series had
evidence of an atrial septal defect either by oximetry series
or by echocardiographic determination after valvuloplasty.
It is possible that the presence of a new atrial septal defect
in some patients may have partially contributed to the de-
crease in pulmonary capillary wedge pressure after valvu-
loplasty. The magnitude of the balloon-induced shunt, how-
ever, was small in four of the six patients, and four of the
six also demonstrated an immediate decrease in pulmonary
vascular resistance. Additional investigation will need to be
done to assess the long-term hemodynamic effect of these
shunts. Improvements in balloon catheter design and con-
struction, resulting in substantially lower profiles for de-
flated balloons, may decrease the incidence of atrial septal
defect in the future.
Several additional problems should be emphasized as
potential complications of mitral valvuloplasty. The tech-
nique must be performed through a trans septal approach
which, by itself, is associated with small but definite risk
of cardiac perforation (17,18). Improper positioning of the
dilation balloon (for example, through mitral chordae) could
theoretically lead to chordal rupture and acute mitral re-
gurgitation. Dislodgement of left atrial clot not detected by
lACC Vol. 9. No.4
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prevalvuloplasty echocardiographic examination could po-
tentially lead to embolic phenomena. Creation of a signif-
icant atrial septal defect secondary to septal dilation could
theoreticallyexpose the patient to a paradoxic embolus(19).
Finally, valvular restenosis may develop in a significant
numberof patients. Becausethe incidence of restenosis after
surgical commissurotomy has been estimated to range from
2 to 60%, with approximately 10% of patients requiring
reoperation in 5 years and 60% within 10 years (20), it
seems likely that significant rates of restenosis will also
occur after balloon valvuloplasty. All of these technical
considerations will have to be addressed to assess the true
efficacy and safety of mitral valvuloplasty .
Conclusion. The present study demonstrates that mitral
valvuloplasty can be accomplished successfully in older adult
patients with moderate to severe calcification of the mitral
valve. Significant lessening of symptoms may result from
improvement in valvular function. The mechanism of suc-
cessful valve dilation involves separation of fused commis-
sures and fracture of nodular calcification. Additional stud-
ies will need to be done to assess the long-term efficacy of
this procedure.
References
I. LockJE. KhalilullahM. Shrivasta S, Bahl V, Keane JF. Percutaneous
catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med
1985;313:151 5- 8.
2. Rocchini AP, Kveselis DA. Snider AR. Beekman RH. Balloon an-
gioplasty for the treatment of mitral stenosis (absm , Circulation
1985;72(suppl 111 ):111-259.
3. Zaibag MA. Kasab SA, Ribeiro PA. Fagih MR. Percutaneous double
balloon mitral valvotomy for rheumatic mitral valve stenosis. Lancet
1986;1:757-61.
4. McKay RG, Lock JE, Keane JF. Safian RD, Aroesty JM, Grossman
W. Percutaneous mitral valvuloplasty in an adult patient with calcific
rheumat ic stenosis. J Am Coli Cardiol 1986:7:1410-5 .
5. Palacios I. Lock JE. Keane JF. Block Pc. Percutaneous transvenous
balloon valvotomy in a patient with severe calcific mitral stenosis. J
Am Coil Cardiol 19X6;7:141 6- 9.
6. Baim DS. Grossman W. Percutaneousapproach and transseptal cath-
eterization. In: Grossman W, ed. Cardiac Catheterization and Angi-
ography. 3rd ed. Philadelphia: Lea & Febiger, 19X6:59-75 .
7. Carabello BA. Grossman W. Calculation of stenotic valveorifice area.
In: Ref. 6:143-54 .
X. Burow RD. Straus HW. Singleton R. et al. Analysis of left ventricular
function from multiple gated acquisition (MUGA) cardiac blood pool
imaging. Circulation 1977:56:1024- 8.
9. Come Pc. Riley MF, McDowell AV. M-mode echocardiography:
recording techniques and normal find ings. In: Come PC. ed. Diag-
nostic Cardiology: Non-invasive Imaging Techniques. Philadelphia:
JB Lippincott. 1985:220-3 .
10. Halle L, Anglesen B. Doppler Ultrasound in Cardiology. Philadelphia:
Lea & Febiger. 1982:77.
II . Weyman AE, Wann LS. Caldwell RL. Negative contrast echocardi-
ography: a new method for detecting left-to-right shunts. Circulation
1979:59:498- 505.
12. Valdes-Cruz LM. Pieroni DR. Roland JMA. Varghese PJ. Echocar-
diographic detection of intracardiac right-to-left shunts following pe-
ripheral vein injections. Circulation 1976:54:558-62.
13. Flamm MD. Cohn KE. Hancock EW. Measurement of systemic car-
diac output at rest and with exercise in patients with atrial septal
defects. Am J Cardiol I969:233:25X- 65.
14. Cohn LH. Collins JJ Jr. Surgical treatmentof mitral stenosis. A med-
ical milestone. N Engl J Med 1973;289:1035-7.
15. Schoen FJ. Collins JJ Jr. Cohn LH. Long-term failure rate and mor-
phological correlations in porcine bioprosthetic heart valves, Am J
Cardiol 19lD:51:957- 64.
16, McKay RG, Safian RD. Lock JE. et al. Balloon dilation of calcific
aortic stenosis in elderly patients. Circulation 1986:74:119- 26.
17. Ross J Jr. Considerations regarding the technique for transseptal left
heart catneterization. Circulation 1966:34:391-9.
IX. Braunwald E. Swan HJC. eds. Cooperative study on cardiac cathe-
terization. Circulation 1968;37(suppl 1lI):1l1-74-9.
19. Corrin C. Paradoxical embolism. Br Heart J 1964:26:549-53.
20. Ellis LB. Singh JB. Morales DD, Harken DE. Fifteen-to-twenty year
study of one thousand patients undergoing closed mitralvalvuloplasty.
Circulation 1973;48:357- 64.
